Beta Bionics BBNX
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 48th percentile, 5-year average -10.8x
Around its usual level · 47th percentile, 5-year average 1.9x
#3277 of 5329 stocks by PB (1 = cheapest)
Below its usual level · 36th percentile, 5-year average 9.0x
#4267 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.22 | – | 1.86 | 47% (cheaper than usual) | #3277 of 5329 (1 = cheapest) |
| PE | -10.74 | -7.99 | -10.78 | 48% (cheaper than usual) | – |
| PS | 7.01 | 5.72 | 8.97 | 36% (cheaper than usual) | #4267 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BBNX.
Sign in to join the discussion.